Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-22
2005-03-22
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S232000
Reexamination Certificate
active
06869968
ABSTRACT:
The invention relates to 2-(3H)-oxazolone derivatives. They may be used as COX-2 inhibitors. The compounds may be used in the treatment of colorectal cancer.
REFERENCES:
patent: 5380738 (1995-01-01), Norman et al.
patent: 5866596 (1999-02-01), Sartori et al.
patent: 0 329 070 (1989-08-01), None
patent: 0 745 596 (1996-04-01), None
patent: WO 9734882 (1997-09-01), None
patent: 96 11188 (1998-03-01), None
patent: WO 9811080 (1998-03-01), None
patent: WO9427980 (1994-12-01), None
Duran Carles Puig
Fernandez Forner Dolors
Noguera Ferran Pujol
Allmirall Prodesfarma S.A.
Coleman Brenda
Haddaway Keith G.
Schneller Marina V.
Venable LLP
LandOfFree
2-(3H)-oxazolone derivatives and their use as COX-2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-(3H)-oxazolone derivatives and their use as COX-2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-(3H)-oxazolone derivatives and their use as COX-2 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3437728